MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells

FEBS Lett. 2014 Aug 25;588(17):3180-5. doi: 10.1016/j.febslet.2014.06.059. Epub 2014 Jul 3.

Abstract

The insulin-like growth factor receptor I (IGF-IR) is a proto-oncogene with potent mitogenic and antiapoptotic activities. It has been reported that expression of IGF-IR is up-regulated in bladder cancer. Here, we assessed whether microRNA-145 (miR-145) regulates IGF-IR expression in bladder cancer. In our study, miR-145 was shown to directly target IGF-IR 3'-untranslated region (UTR) in human bladder cancer cells. Small interfering RNA (siRNA)- and miR-145-mediated IGF-IR knockdown experiments revealed that miR-145 promotes cell apoptosis, and suppresses cell proliferation and migration through suppression of IGF-IR expression. Taken together, our data suggest that miR-145 may inhibit bladder cancer initiation by affecting IGF-IR signaling.

Keywords: Apoptosis; Bladder cancer; IGF-IR; Migration; Proliferation; miR-145.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / genetics
  • Apoptosis / genetics
  • Base Sequence
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Gene Silencing
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Proto-Oncogene Mas
  • RNA, Small Interfering / genetics
  • Receptor, IGF Type 1 / deficiency
  • Receptor, IGF Type 1 / genetics*
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / pathology*

Substances

  • 3' Untranslated Regions
  • MAS1 protein, human
  • MIRN145 microRNA, human
  • MicroRNAs
  • Proto-Oncogene Mas
  • RNA, Small Interfering
  • Receptor, IGF Type 1